# Real-Life Outcomes of TAF/FTC/BIC in HIV Patients in Colombia

> **NCT06829082** · — · COMPLETED · sponsor: **Servicios de Salud IPS Suramericana S.A.S** · enrollment: 161 (actual)

## Conditions studied

- HIV Treatment

## Interventions

- **DRUG:** BIKTARVY 50Mg-200Mg-25Mg Tablet

## Key facts

- **NCT ID:** NCT06829082
- **Lead sponsor:** Servicios de Salud IPS Suramericana S.A.S
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2024-11-15
- **Primary completion:** 2025-01-17
- **Final completion:** 2025-01-17
- **Target enrollment:** 161 (ACTUAL)
- **Last updated:** 2025-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06829082

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06829082, "Real-Life Outcomes of TAF/FTC/BIC in HIV Patients in Colombia". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06829082. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*